Assessment of the Effect of the Product RV2666C Formula LA2984 Compared to an Untreated Area With an Epidermally Ablated Skin Model Obtained With an Erbium YAG Laser on Adults Presenting IV to VI Skin Phototype

In this study, we assess the efficacy of a cosmetic product in adults with IV to VI skin phototype. This study is conducted as a monocentric, controlled, compared with an untreated area and randomized for the area of product application. To perform this clinical study, minimum 20 - maximum 24 subjects (man or woman), aged from 18 to 50 years are enrolled. The subjects applied the investigational product on an area located on the anterior side of the forearm, following the laser YAG act, once a day and under occlusion from Day 1 to Day 3 included. Then it is applied twice a day in an open way from Day 4 until Day 18 included. 10 visits are planned: * Visit 1: Inclusion visit = Day 1 * Visit 2 to Visit 5: Intermediate visits = Day 2 to Day 5 * Visit 6: Intermediate visit = Day 8 * Visit 7: Intermediate visit = Day 10 * Visit 8: Intermediate visit = Day 12 * Visit 9: Intermediate visit = Day 15 * Visit 10: End of study visit = Day 19-1

NCT Number	NCT07166484
Lead Sponsor	Pierre Fabre Dermo Cosmetique
Conditions	Healthy
Enrollment	22 participants
Start Date	2025-09-15
Primary Completion	2025-12-05 (estimated)
Study Completion	2025-12-05 (estimated)
Updated on ClinicalTrials.gov	2026-05-05